Achillion Pharmaceuticals, Inc. (ACHN) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

88% of 8 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 10/24/2014 1 month $11.71 $11.75 +0.34% -1 Active
Comments:
markkabbash markkabbash 09/12/2014 1 day $12.67 $11.06 -12.71% 12 Ended
Comments:
NBGuyver NBGuyver 09/08/2014 3 months $12.75 $11.75 -7.84% -7 Active
Comments:
09/06/2014 3 months $12.17 $11.75 -3.45% -3 Active
Comments: DOVREBBE DARE BUONI RISULTATI
marzios marzios 09/05/2014 3 months $12.17 $11.75 -3.45% -3 Active
Comments: undervalued, phase II pass, phase III is soon.
Lyn126 Lyn126 08/23/2014 3 months $9.76 $11.75 +20.39% 20 Active
Comments:
jipi jipi 06/25/2014 1 Year $7.59 $11.75 +54.81% 54 Active
Comments: this stock is technically bullish (candlesticks, MACD...)
InvestorsXpress InvestorsXpress 06/16/2014 1 Year $6.47 $11.75 +81.61% 81 Active
Comments:
mrhofmann mrhofmann 06/04/2014 1 day $2.71 $2.84 +4.8% 4 Ended
Comments:
rjbrandao rjbrandao 11/04/2013 1 month $2.71 $3.26 +20.3% 20 Ended
Comments:
philipthomas philipthomas 11/01/2013 3 months $2.53 $3.34 +32.02% 32 Ended
Comments: god's gift to those needing to get back to even ... Read the full entry
sv087 sv087 10/31/2013 1 month $2.51 $3.46 +38.12% 38 Ended
Comments: Oversold, undervalued. Short squeeze, then leveling off.
danipre danipre 10/05/2013 3 months $2.72 $3.30 +21.32% 21 Ended
Comments: Fabulous opportunity at this level
yumatiger yumatiger 02/09/2010 3 months N/A Ended
Comments: Good fundamentals and potential

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.